3136 results for «2961»

Filter By

3136 results

Successful finale - Latest best practices and technologies for large hole arterial and venous closure

22 May 2025 – From EuroPCR 2025

This session covers the latest best practices and technologies for large hole arterial and venous closure, focusing on minimising vascular complications.

Learn about a novel patch-based closure system with encouraging early results in TAVI cases, highlighting the importance of deployment angle and ultrasound guidance.

The venous case presentation...

Successful finale - Latest best practices and technologies for large hole arterial and venous closure

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

20 May 2025 – From EuroPCR 2025

Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

Symplicity Spyral renal denervation: more insights from clinical practice

21 May 2025 – From EuroPCR 2025

Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...

Symplicity Spyral renal denervation: more insights from clinical practice

The future is now: QFR and RMS to optimise coronary artery disease patient management

20 May 2025 – From EuroPCR 2025

See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...

The future is now: QFR and RMS to optimise coronary artery disease patient management

The impact of paravalvular leak, permanent pacemaker implantation and the planning for reinterventions on lifetime management in TAVI patients

22 May 2025 – From EuroPCR 2025

How do paravalvular leak, pacemaker implantation and reintervention planning shape lifetime outcomes in TAVI patients?

This session examines these crucial aspects through the case of a 77-year-old male with bicuspid aortic valve stenosis, HFpEF and multiple comorbidities, including diabetes, obesity and sleep apnoea.

Follow the discussion to understand...

The impact of paravalvular leak, permanent pacemaker implantation and the planning for reinterventions on lifetime management in TAVI patients

Ultrasound renal denervation is now guideline-recommended: how do I get started?

20 May 2025 – From EuroPCR 2025

Ultrasound renal denervation (uRDN) is now guideline-recommended—are you ready to bring it into practice? This EuroPCR 2025 session offers everything you need to get started: review key results from Sham-controlled and off-medication trials confirming the efficacy and safety of RDN; understand why both the ESC and...

Ultrasound renal denervation is now guideline-recommended: how do I get started?

Techniques for the treatment of left main lesions

20 May 2025 – From EuroPCR 2025

Discover contemporary techniques for treating left main coronary artery lesions with a focus on ultra low-contrast PCI, management of calcified Medina 0-0-1 lesions, and troubleshooting intravascular lithotripsy. This session provides practical insights into complex lesion treatment to enhance safety and efficacy.

Techniques for the treatment of left main lesions

Valve choice - Shaping index procedures and lifetime patient management

22 May 2025 – From EuroPCR 2025

This session addresses recent advancements and ongoing challenges in transcatheter aortic valve implantation (TAVI), with a particular focus on valve selection during index procedures. Presentations include data from the Accurate IDE trial, highlighting the prognostic implications of valve underexpansion. A clinical case involving an 80-year-old patient with severe...

Valve choice - Shaping index procedures and lifetime patient management

Invasive treatment of refractory angina

20 May 2025 – From EuroPCR 2025

Explore invasive treatment options for refractory angina through clinical case presentations emphasizing coronary physiology guidance, coronary microvascular disease management, and innovative therapies such as coronary sinus reducer implantation. This session highlights provocative test-guided approaches to optimize patient outcomes.

Invasive treatment of refractory angina

Why should laser atherectomy be part of your complex PCI algorithm?

21 May 2025 – From EuroPCR 2025

Watch this EuroPCR 2025 session to see how ELCA can make the difference in two challenging cases: a severely calcified, undilatable lesion, and an uncrossable one. Learn how pre- and peri-procedural imaging (CT, IVUS, OCT) supports tailored decision-making, and how ELCA enables safe and effective lesion...

Why should laser atherectomy be part of your complex PCI algorithm?

Nurses and allied professionals abstracts session

20 May 2025 – From EuroPCR 2025

Highlight the pivotal role of nurses and allied health professionals in interventional cardiology through a series of abstracts addressing radial haemostasis, TAVI nursing programs, early mobilization, radiation protection, and physiologist-led intracoronary thermodilution assessments.

Nurses and allied professionals abstracts session

How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction

21 May 2025 – From EuroPCR 2025

Discover the latest on managing coronary microvascular dysfunction (CMD) with insights from EuroPCR 2025. This session explores how physiology testing helps identify CMD endotypes in the cathlab and highlights the limitations of ETT for patients experiencing angina or dyspnea at rest. Learn about the A-FLUX coronary...

How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction

How to manage coronary artery disease in TAVI candidates?

20 May 2025 – From EuroPCR 2025

Understand the comprehensive management of coronary artery disease (CAD) in patients undergoing transcatheter aortic valve implantation (TAVI). This session reviews evidence-based evaluation, decision-making, and treatment strategies for significant coronary lesions, including severe left main and multivessel disease, illustrated through detailed case studies.

How to manage coronary artery disease in TAVI candidates?

Role of imaging in ACS: from non-invasive to invasive investigations

20 May 2025 – From EuroPCR 2025

Explore the critical role of imaging in acute coronary syndrome (ACS) from non-invasive coronary CT angiography to invasive intracoronary imaging modalities. This session covers detection of culprit lesions, diagnostic strategies, and PCI optimization through real-world case examples.

Role of imaging in ACS: from non-invasive to invasive investigations

Getting started with a renal denervation programme

20 May 2025 – From EuroPCR 2025

Begin your renal denervation program with this comprehensive session focusing on the importance of a multidisciplinary hypertension team, procedural techniques with current devices, and expected clinical outcomes across patient subgroups. Practical case examples illustrate effective team-based hypertension management and procedural execution.

Getting started with a renal denervation programme

TAVI in patients with a small annulus

20 May 2025 – From EuroPCR 2025

Address the unique challenges of transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli. This session discusses comparative outcomes of balloon-expandable versus self-expandable valves, size prediction methodologies, and management of paravalvular regurgitation in low-flow, low-gradient aortic stenosis cases.

TAVI in patients with a small annulus

Degeneration of TAVI valves: a new target for innovations

19 May 2025 – From EuroPCR 2025

Discover the latest innovations targeting degeneration of TAVI valves, including expert presentations and cutting-edge technologies like The Splitter, an enabler for transcatheter aortic valve-in-valve implantation.

Degeneration of TAVI valves: a new target for innovations

The Jon DeHaan Foundation Award competition

19 May 2025 – From EuroPCR 2025

Witness innovation in action at the Jon DeHaan Foundation Award competition featuring groundbreaking technologies like synchronized diaphragmatic stimulation for heart failure and novel devices for aortic bioprosthesis and interatrial shunting.

The Jon DeHaan Foundation Award competition

New evidence for treatment of calcified coronary artery disease

20 May 2025 – From EuroPCR 2025

Explore the latest randomized trials and studies advancing the treatment of calcified coronary artery disease. This session covers cutting balloon use, lithotripsy versus conventional preparation, and one-year outcomes comparing rotational atherectomy, lithotripsy, and laser. Also highlighted is the EMPOWER CAD study focusing on women treated with...

New evidence for treatment of calcified coronary artery disease

What is new in atrioventricular valves?

19 May 2025 – From EuroPCR 2025

Discover the latest advancements in atrioventricular valve interventions, including innovative transcatheter repair technologies and first-in-human experiences with novel devices.

What is new in atrioventricular valves?
Didn’t find what you were looking for?